Gainers
- Anitra AZTR stock rose 17.0% to $0.17 during Friday's after-market session. The company's market cap stands at $5.0 million.
- Scinai Immunotherapeutics SCNI stock increased by 12.79% to $3.35. The company's market cap stands at $1.9 million.
- Salarius Pharmaceuticals SLRX shares moved upwards by 9.17% to $0.45. The company's market cap stands at $2.1 million.
- TRACON Pharma TCON stock rose 8.77% to $1.24. The market value of their outstanding shares is at $3.3 million.
- TransCode Therapeutics RNAZ stock increased by 6.36% to $1.17. The market value of their outstanding shares is at $7.7 million.
- China Pharma Holdings, Inc. Common Stock CPHI shares rose 5.64% to $0.28.
Losers
- Aethlon Medical AEMD stock fell 7.8% to $0.54 during Friday's after-market session. The company's market cap stands at $2.7 million.
- Sunshine Biopharma SBFM shares decreased by 7.68% to $0.52. The company's market cap stands at $9.7 million.
- Tevogen Bio Holdings TVGN shares declined by 6.41% to $0.78. The company's market cap stands at $128.7 million.
- Rezolute RZLT shares fell 5.95% to $5.38. The market value of their outstanding shares is at $215.9 million.
- Senti Biosciences SNTI shares declined by 5.92% to $0.26. The company's market cap stands at $12.0 million.
- Tiziana Life Sciences TLSA shares decreased by 5.01% to $0.95. The market value of their outstanding shares is at $96.4 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
AZTRAzitra Inc
$0.42231.76%
CPHIChina Pharma Holding Inc
$0.1700-2.30%
RNAZTransCode Therapeutics Inc
$3.801.06%
RZLTRezolute Inc
$4.39-%
SBFMSunshine Biopharma Inc
$2.70-2.88%
SCNIScinai Immunotherapeutics Ltd
$3.20-5.88%
SLRXSalarius Pharmaceuticals Inc
$1.43-7.74%
SNTISenti Biosciences Inc
$3.91-1.51%
TCONTRACON Pharmaceuticals Inc
$0.0322-%
TLSATiziana Life Sciences Ltd
$0.7749-0.01%
TVGNTevogen Bio Holdings Inc
$0.9960-%
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in